Related Experiment Video
Updated: Feb 15, 2026

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
[Prognostic Value of Geriatric Screening Tools in Elderly Cancer Patients]
1Dept. of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University.
Abstract:
The elderly population is heterogeneous. Chronological age alone does not reflect heterogeneity in the aging process. It is recommended that elderly cancer patients should be evaluated for some form of geriatric assessment(GA)to detect problems, to predict treatment-related toxicities, to predict functional decline, to predict prognosis, and to assist in cancer treatment decisions. It was reported that functional status, nutritional status, mental status, polypharmacy, and comorbidity were independent prognostic factors for survival in elderly cancer patients. Although a full GA is valuable, it is time-consuming. Therefore, in a busy practice, geriatric screening tools are useful to identify patients in need of further evaluation using a full GA. Assessment for screening tools takes a few minutes. Some screening tools such as Geriatric 8(G8), Vulnerable Elders Survey-13(VES-13), Groningen Frailty Indicator(GFI), and Flemish version of the Triage Risk Screening Tool(fTRST)have prognostic value for survival. These screening tools may help physicians make informed treatment decisions in daily practice.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

